Taisei Masuda

Meguro, 1528552, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Influence of extrusion direction on hydroxyapatite coating formation, corrosion and mechanical performance of a Mg-Zn-Zr alloy.

Influence of extrusion direction on hydroxyapatite coating formation, corrosion and mechanical performance of a Mg-Zn-Zr alloy.

Journal: Journal of the mechanical behavior of biomedical materials

Published: February 11, 2026

Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial.

Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial.

Journal: Human vaccines & immunotherapeutics

Published: January 13, 2025

Fabrication and Characterization of Biomedical Ti-Mg Composites via Spark Plasma Sintering.

Fabrication and Characterization of Biomedical Ti-Mg Composites via Spark Plasma Sintering.

Journal: Materials (Basel, Switzerland)

Published: June 15, 2024

Total Synthesis of (-)-Enigmazole A by the Macrocyclization/Transannular Pyran Cyclization Strategy.

Total Synthesis of (-)-Enigmazole A by the Macrocyclization/Transannular Pyran Cyclization Strategy.

Journal: Organic letters

Published: February 29, 2024

One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial.

One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial.

Journal: Vaccine

Published: May 26, 2023

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial.

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial.

Journal: Human vaccines & immunotherapeutics

Published: May 04, 2023

Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.

Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.

Journal: Vaccine

Published: December 11, 2022

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.

Journal: Vaccine

Published: March 09, 2022

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.

Journal: Vaccine

Published: January 21, 2022

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines.

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines.

Journal: NPJ vaccines

Published: December 23, 2021

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.

Journal: Vaccine

Published: November 12, 2021

Nationwide epidemiologic study of norovirus-related hospitalization among Japanese older adults.

Nationwide epidemiologic study of norovirus-related hospitalization among Japanese older adults.

Journal: BMC infectious diseases

Published: August 29, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026